Protara Therapeutics, Inc. Accrued Liabilities, Current
Protara Therapeutics, Inc. (TARA) had Accrued Liabilities, Current of $7.37 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-11
- 2026-06-30: Accrued Liabilities, Current $7.37M.
- 2026-03-31: Accrued Liabilities, Current $3.63M.
- 2025-12-31: Accrued Liabilities, Current $6.23M.
- 2025-09-30: Accrued Liabilities, Current $4.18M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $7.37M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $3.63M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $6.23M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $4.18M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $3.26M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $3.54M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $5.41M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $5.27M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $3.23M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $3.53M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $2.73M 10-K · filed 2025-03-05 | |
| 2023-09-30 | $3.31M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $2.13M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $1.40M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $3.24M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $2.35M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $2.22M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.45M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $2.49M 10-K · filed 2023-03-08 | |
| 2021-09-30 | $1.92M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.44M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $1.37M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $1.91M 10-K · filed 2022-03-09 | |
| 2020-09-30 | $1.57M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.58M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $995.59K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $2.63M 10-K · filed 2021-03-11 | $320.00K 10-K · filed 2020-03-20 |
| 2019-09-30 | $1.22M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $2.00M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $1.56M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $2.64M 10-K · filed 2020-03-20 | |
| 2018-09-30 | $2.15M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $1.80M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $2.00M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $8.95M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $8.87M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $2.94M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $2.55M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $4.52M 10-K · filed 2018-03-14 | |
| 2016-09-30 | $4.19M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $3.97M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $2.84M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $2.58M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $2.23M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $2.20M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $1.43M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $1.42M 10-K · filed 2016-03-14 | |
| 2014-09-30 | $1.61M 10-Q · filed 2014-11-25 | |
| 2013-12-31 | $984.00K 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |